Module 80

Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
General Properties
Below we list the number of gene sets from which the module was composed was originally composed, and the number of genes and experiments that it contains. Clicking on the number of genes will display a detailed list of all the genes in the module. Clicking on the number of experiments will display a detailed list of all the experiments in the module.
Num gene sets: 4
Num genes: 32 (see 1265 additional genes for this module)
Num experiments: 148 (62 induced, 86 repressed)
Parent module: 200
Children modules: 51


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Gene sets
Below we list the gene sets from which the module was originally composed. Clicking on a gene set will display all the genes associated with that gene set. Also listed are all the other modules in which the gene set participates.
post_embryonic morphogenesis
post_embryonic development
eye photoreceptor cell fate commitment
compound eye morphogenesis (sensu Drosophila)


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Enriched clinical annotations
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched.
Clinical annotation Category P-value Hits Hits(%) Module hits in category Arrays in annotation Arrays
B cells (Leukemia) Leukemia 6.3e-06 16 94.1 17 62 141
Cell line (Breast cancer) Breast cancer 1.2e-05 10 71.4 14 30 152
Bone marrow (Leukemia) Leukemia 1.8e-05 10 58.8 17 23 141
Centroblasts (Various tumors) Various tumors 6.6e-05 3 75 4 5 154
GC B like DLBCL (Various tumors) Various tumors 6.6e-05 3 75 4 5 154
Acute leukemia (Leukemia*) Leukemia* 8.4e-05 17 19.7 86 141 1945
Cancer and cell line (Leukemia*) Leukemia* 8.4e-05 17 19.7 86 141 1945
Cancer (Leukemia*) Leukemia* 8.4e-05 17 19.7 86 141 1945
Hematologic cancer and cell line (Leukemia*) Leukemia* 8.4e-05 17 19.7 86 141 1945
Hematologic cancer (Leukemia*) Leukemia* 8.4e-05 17 19.7 86 141 1945
Hematologic samples and cell lines (Leukemia*) Leukemia* 8.4e-05 17 19.7 86 141 1945
Leukemia (Leukemia*) Leukemia* 8.4e-05 17 19.7 86 141 1945
Leukemia or leukemia cell line (Leukemia*) Leukemia* 8.4e-05 17 19.7 86 141 1945
Monocytes (Leukemia*) Leukemia* 8.4e-05 17 19.7 86 141 1945
Normal female hormonal tissue and cells (Various tumors) Various tumors 9.3e-05 3 100 3 8 154
Normal female hormonal tissue (Various tumors) Various tumors 9.3e-05 3 100 3 8 154
Cancer and cell line (NCI60*) NCI60* 0.0002 13 20.9 62 138 1945


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Enriched GO annotations
For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column).
GO annotation P-value Hits Hits(%) Module genes Genes in annotation Genes
post-embryonic morphogenesis 1.1e-69 31 96.8 32 41 4566
post-embryonic development 4.4e-69 31 96.8 32 42 4566
compound eye morphogenesis (sensu Drosophila) 2.8e-62 29 90.6 32 41 4566
eye photoreceptor cell fate commitment 1.9e-60 28 87.5 32 38 4566
transmembrane receptor protein tyrosine kinase signaling pathway 1.6e-54 28 87.5 32 52 4566
morphogenesis 2.3e-36 32 100 32 366 4566
transmembrane receptor protein tyrosine kinase activity 3.0e-31 20 62.5 32 62 4566
development 2.1e-30 32 100 32 554 4566
transmembrane receptor protein kinase activity 2.6e-30 20 62.5 32 68 4566
protein kinase activity 2.4e-26 20 62.5 32 102 4566
protein amino acid phosphorylation 6.4e-19 20 62.5 32 230 4566
receptor activity 3.8e-17 25 78.1 32 582 4566
transmembrane receptor activity 4.6e-17 23 71.8 32 448 4566
response to DNA damage stimulus 2.5e-16 20 62.5 32 310 4566
protein tyrosine kinase activity 3.1e-16 15 46.8 32 120 4566
ephrin receptor activity 3.6e-16 8 25 32 11 4566
porin activity 8.3e-16 18 56.2 32 235 4566
signal transducer activity 7.2e-15 28 87.5 32 1026 4566
ATP binding 3.6e-14 20 62.5 32 399 4566
nucleotidyltransferase activity 1.2e-13 20 62.5 32 425 4566
channel/pore class transporter activity 1.0e-12 18 56.2 32 351 4566
response to stress 1.3e-11 23 71.8 32 792 4566
integral to plasma membrane 1.1e-08 18 56.2 32 612 4566
eye morphogenesis (sensu Drosophila) 2.9e-08 4 12.5 32 6 4566
MHC protein binding 3.0e-06 3 9.3 32 5 4566
coreceptor activity 3.6e-05 3 9.3 32 10 4566
T-cell activation 6.3e-05 8 25 32 207 4566
lymphocyte activation 6.8e-05 8 25 32 209 4566


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Visual display
Below is a visual display of the module. Shown are those arrays in which the module's genes significantly change, and the direction of change (induction/repression) in each array is indicated (middle, labeled 'Module changes'; red/green row). The arrays that correspond to the significant clinical attributes are also shown (top; brown rows). The gene sets that compose the module are also shown (left) along with an indication of the membership of the module genes in these gene sets.
You can also view the images within GeneXPress by loading the module gxp file file.
 
 





 >4x